PhaseRx (PZRXQ) Short Interest Ratio & Short Volume

Short interest is the volume of PhaseRx shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 100 shares of PZRXQ short. Learn More on PhaseRx's current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PhaseRx: Alvotech (0.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling PZRXQ is an investing strategy that aims to generate trading profit from PhaseRx as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for PhaseRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PZRXQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PZRXQ, twice per month. The most recent reporting period available is October, 31 2024.